Tech Company Financing Transactions
Icon Bioscience Funding Round
Icon Bioscience secured a $5.3 million investment round on 12/4/2015. Investors included private investors.
Transaction Overview
Company Name
Announced On
12/4/2015
Transaction Type
Debt
Amount
$5,316,245
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1253 Reamwood Ave.
Sunnyvale, CA 94089
USA
Sunnyvale, CA 94089
USA
Phone
Website
Email Address
Not Recorded
Overview
Icon Bioscience Inc. (IBI) a privately held specialty biopharma company, developing a broad portfolio of advanced, biodegradable, sustained-released intraocular ophthalmic products, based on its Verisome drug delivery technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Vernon Wong
Chief Executive Officer
David Tierney
Browse more venture capital transactions:
Prev: 12/3/2015: ORIC Pharmaceuticals venture capital transaction
Next: 12/4/2015: Trufa venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs